HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use TIGAN® safely and effectively. See full prescribing information for TIGAN®.
TIGAN® (trimethobenzamide hydrochloride) capsule, for oral use
Initial U.S. Approval: 1974
INDICATIONS AND USAGE
Tigan is an antiemetic indicated in adults for the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis. (1)
Limitation of Use:
DOSAGE AND ADMINISTRATION
DOSAGE FORMS AND STRENGTHS
Capsule: 300 mg of trimethobenzamide hydrochloride. (3)
Known hypersensitivity to trimethobenzamide. (4)
WARNINGS AND PRECAUTIONS
Adverse reactions include hypersensitivity reactions and Parkinson-like symptoms; blood dyscrasias, blurring of vision, coma, convulsions, depression of mood, diarrhea, disorientation, dizziness, drowsiness, headache, jaundice, muscle cramps, and opisthotonos. (6)
To report SUSPECTED ADVERSE REACTIONS, contact Pfizer, Inc. at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
See 17 for PATIENT COUNSELING INFORMATION.
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.